←
Atara Bio707 posts
Atara Bio avatar

Atara Bio

@Atarabio

Atara Biotherapeutics $ATRA develops next-gen #CART therapies & off-the-shelf allogeneic #TCellRx #immunotherapy for cancer & #MS #EBV+ #PTLD #celltherapy

◷ Joined July 2017▧ 524 Photos and videos
Atara Bio avatar
Atara Bio@Atarabio·6 Mar 2024

Tune in now for a cell therapy panel with CEO Pascal Touchon at Cowen Inc.’s 44th Annual Healthcare Conference. A link to the live webcast can be found in the investor section of our website: lnkd.in/gFWidVC7

Post attachment
Atara Bio avatar
Atara Bio@Atarabio·4 Jan 2024

Next week, our CEO Pascal Touchon is heading to San Francisco to share Atara's latest pipeline progress & key development milestones at the J.P. Morgan Annual Healthcare Conference on Thursday, January 11 at 9:45 a.m. PT: bit.ly/3H8hXrd #CART #JPM24

Post attachment
Atara Bio avatar
Atara Bio@Atarabio·8 Dec 2023

We’re heading to San Diego for #ASH23 to share positive new preclinical B-cell malignancy data for ATA3431, an investigational next-generation #allogeneic CD20/CD19-targeted CAR #EBV T-cell therapy. Be sure to stop by and check out our poster on Dec. 11.

Post attachment
Atara Bio avatar
Atara Bio@Atarabio·1 Nov 2023

Today we announced Atara entered an expanded global tab-cel® partnership with Pierre Fabre Laboratories. Tune in to our conference call and live webcast at 9:00 a.m. EDT to hear more and other third quarter 2023 corporate updates. bit.ly/45WNUga #EBV #MS #CART #PTLD

Post attachment
Atara Bio avatar
Atara Bio@Atarabio·23 Oct 2023

While autologous T-cell therapies have been life-changing for many patients, allogeneic approaches hold the promise of personalized, off-the-shelf treatments manufactured at scale, stored and ready for rapid delivery. Learn more about Atara’s approach: bit.ly/3CrLs50

Post attachment
Atara Bio avatar
Atara Bio@Atarabio·18 Oct 2023

Atara’s EBV T-cell platform has the potential to address a wide range of EBV-driven diseases or other serious diseases through the incorporation of engineered #CARs. Learn more about our versatile platform: bit.ly/3CrLs50

0:16
Atara Bio avatar
Atara Bio@Atarabio·11 Oct 2023

Today, our CSO & CTO, Cokey Nguyen, joins @alliancerm's #CGMesa23 to discuss how the world’s first-ever approval of an allogeneic T-cell therapy helped galvanize the #celltherapy field, paving the way to make further inroads into our fight against cancer and autoimmune disorders.

Post attachment
Atara Bio avatar
Atara Bio@Atarabio·10 Oct 2023

On #WorldMentalHealthDay, we emphasize our commitment to promoting mental well-being within our organization and beyond. Our Spring Health Mental Wellness Benefit empowers Atarians with the resources to focus on our mission of developing therapies to transform patients' lives.

Post attachment
Atara Bio avatar
Atara Bio@Atarabio·6 Oct 2023

At Atara, we are using allogeneic Epstein-Barr virus (#EBV) T cells as a platform to develop investigational therapies for cancer and autoimmune diseases. Learn more about our pipeline: bit.ly/3qq01Um

0:18